These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37899662)

  • 21. Dermatological manifestations associated with COVID-19 and COVID-19 vaccination: results from the Lebanese COVID registry.
    Chrabieh R; Haddad I; Salameh P; Kurban M; Kechichian E; Habre M; Ayoub N; Torbey G; El Sayed F; Maamari M; Tannous Z; Farra A; ; El Khoury J
    Int J Dermatol; 2023 Oct; 62(10):1248-1256. PubMed ID: 37638543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous adverse reactions of COVID-19 vaccines: A systematic review.
    Qaderi K; Golezar MH; Mardani A; Mallah MA; Moradi B; Kavoussi H; Shamsabadi A; Golezar S
    Dermatol Ther; 2022 May; 35(5):e15391. PubMed ID: 35194894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Herpes Zoster Following COVID-19 Vaccination.
    David E; Landriscina A
    J Drugs Dermatol; 2021 Aug; 20(8):898-900. PubMed ID: 34397201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.
    McMahon DE; Amerson E; Rosenbach M; Lipoff JB; Moustafa D; Tyagi A; Desai SR; French LE; Lim HW; Thiers BH; Hruza GJ; Blumenthal KG; Fox LP; Freeman EE
    J Am Acad Dermatol; 2021 Jul; 85(1):46-55. PubMed ID: 33838206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine.
    Pirrotta P; Tavares-Da-Silva F; Co M; Lecrenier N; Hervé C; Stegmann JU
    Drug Saf; 2021 Dec; 44(12):1341-1353. PubMed ID: 34622421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global incidence pattern and factors associated with common cutaneous reactions related to COVID-19 vaccination of 2.55 million participants in real-world settings: A systematic review and meta-analysis.
    Guo Y; Cao XS; Yang HT; Zhou MG; Yu B
    J Glob Health; 2023 Feb; 13():06008. PubMed ID: 36757823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactogenicity within the first week after Sinopharm, Sputnik V, AZD1222, and COVIran Barekat vaccines: findings from the Iranian active vaccine surveillance system.
    Enayatrad M; Mahdavi S; Aliyari R; Sahab-Negah S; Nili S; Fereidouni M; Mangolian Shahrbabaki P; Ansari-Moghaddam A; Heidarzadeh A; Shahraki-Sanavi F; Fateh M; Khajeha H; Emamian Z; Behmanesh E; Sheibani H; Abbaszadeh M; Jafari R; Valikhani M; Binesh E; Vahedi H; Chaman R; Sharifi H; Emamian MH
    BMC Infect Dis; 2023 Mar; 23(1):150. PubMed ID: 36899326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous adverse reactions following COVID-19 vaccinations: A systematic review and meta-analysis.
    Shafie'ei M; Jamali M; Akbari Z; Sarvipour N; Ahmadzade M; Ahramiyanpour N
    J Cosmet Dermatol; 2022 Sep; 21(9):3636-3650. PubMed ID: 35861631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older.
    Choi YY; Kim MK; Kwon HC; Kim GH
    J Korean Med Sci; 2021 Nov; 36(45):e318. PubMed ID: 34811980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases.
    Català A; Muñoz-Santos C; Galván-Casas C; Roncero Riesco M; Revilla Nebreda D; Solá-Truyols A; Giavedoni P; Llamas-Velasco M; González-Cruz C; Cubiró X; Ruíz-Villaverde R; Gómez-Armayones S; Gil Mateo MP; Pesqué D; Marcantonio O; Fernández-Nieto D; Romaní J; Iglesias Pena N; Carnero Gonzalez L; Tercedor-Sanchez J; Carretero G; Masat-Ticó T; Rodríguez-Jiménez P; Gimenez-Arnau AM; Utrera-Busquets M; Vargas Laguna E; Angulo Menéndez AG; San Juan Lasser E; Iglesias-Sancho M; Alonso Naranjo L; Hiltun I; Cutillas Marco E; Polimon Olabarrieta I; Marinero Escobedo S; García-Navarro X; Calderón Gutiérrez MJ; Baeza-Hernández G; Bou Camps L; Toledo-Pastrana T; Guilabert A
    Br J Dermatol; 2022 Jan; 186(1):142-152. PubMed ID: 34254291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic oral diseases secondary to COVID-19 infection or vaccination: clinical cases and a narrative review.
    Fitzpatrick S; Cha S; Katz J; Migliorati C
    Quintessence Int; 2024 May; 55(5):400-411. PubMed ID: 38415994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review.
    Wang CS; Chen HH; Liu SH
    J Formos Med Assoc; 2022 May; 121(5):1003-1007. PubMed ID: 35012825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse cutaneous reactions reported post COVID-19 vaccination in Al Buraimi governorate, Sultanate of Oman.
    Al Salmi A; Al Khamisani M; Al Shibli A; Al Maqbali S
    Dermatol Ther; 2022 Nov; 35(11):e15820. PubMed ID: 36097882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination.
    Larson V; Seidenberg R; Caplan A; Brinster NK; Meehan SA; Kim RH
    J Cutan Pathol; 2022 Jan; 49(1):34-41. PubMed ID: 34292611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concomitant Severe Psoriasis and Bullous Pemphigoid Induced by COVID-19.
    Martora F; Battista T; Fabbrocini G; Megna M
    Trop Med Infect Dis; 2023 Feb; 8(2):. PubMed ID: 36828523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous reactions to vaccinations.
    Rosenblatt AE; Stein SL
    Clin Dermatol; 2015; 33(3):327-32. PubMed ID: 25889134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous reactions following COVID-19 vaccination assessed by dermatologists: a single-institutional study in Germany.
    Wang R; Mathes S; Claussen C; Biedermann T; Brockow K
    J Dtsch Dermatol Ges; 2023 Mar; 21(3):255-262. PubMed ID: 36892192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous Adverse Drug Reactions (CADRs) to COVID19 Vaccines: A Case Series.
    Purushottam M; Rangappa V; Betkerur JB; Kombettu AP; Shastry V
    Indian Dermatol Online J; 2023; 14(3):383-387. PubMed ID: 37266107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curbing COVID-19 Vaccine Hesitancy from a Dermatological Standpoint: Analysis of Cutaneous Reactions in the Vaccine Adverse Event Reporting System (VAERS) Database.
    Falotico JM; Desai AD; Shah A; Ricardo JW; Lipner SR
    Am J Clin Dermatol; 2022 Sep; 23(5):729-737. PubMed ID: 35931925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al.
    Martora F; Villani A; Marasca C; Fabbrocini G; Ruggiero A
    Australas J Dermatol; 2023 Feb; 64(1):e103-e105. PubMed ID: 36683345
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.